Abstract
Background It is well established that there are different asthma phenotypes, but whereas determinants of atopic asthma are well studied, little is known about non-atopic asthma. We compared risk factors for atopy, atopic asthma (AA) in atopics, and non-atopic asthma (NAA) in non-atopics, in children in a wide variety of countries.
Methods Using four studies, across 23 countries, we assessed asthma status and atopy (skin prick tests) for children aged 6-17, plus risk factors from housing, heating, pets, family, diet, and air-quality categories. Using mixed effects logistic regression models we assessed 4 pathways to asthma: Pathway 1: comparing NAA with non-atopic non-asthma (risk factors for NAA); Pathway 2: comparing atopic non-asthma with non-atopic non-asthma (risk factors for atopy); Pathway 3: comparing AA with atopic non-asthma (risk factors for AA); Pathway 4: comparing AA with non-atopic non-asthma (risk factors for atopy and AA together).
Results Our final sample of 32741 children comprised 67% with neither atopy nor asthma, 15% with atopybut without asthma, 8% with AA and 10% with NAA. Risk factors were similar for AA in atopic children and NAA in non-atopic children (Pearson’s correlation = 0.81, 95% confidence interval = [0.68, 0.94]). In contrast, risk factors for atopy in children without asthma differed from those for AA in atopic children (−0.06, [−0.29, 0.17]).
Discussion These findings indicate that although atopy increases the risk of asthma, the risk factors for subsequently developing asthma are generally the same in those with and without atopy. This raises important questions about the role of atopy in asthma, particularly whether it is an inherent part of the aetiological process or is coincidental.
What is already known on this topic It is well established that there are different phenotypes of asthma but little is known about risk factors for non-atopic asthma.
What this study adds Using a novel approach, we found that lifestyle and environmental risk factors for developing asthma are generally similar in atopic children and non-atopic children but the risk factors for atopy are quite different.
How this study might affect research, practice or policy Our findings suggest that atopy and asthma may be coincidental in a large proportion of children who are defined as having atopic asthma. This has important implications for our understanding of the causes and mechanisms of different asthma phenotypes, and therefore prevention and treatment of asthma.
Competing Interest Statement
MLB has received grants from the Wellcome Trust and the NIHR. AAC has received grants from NIH, ERC and NIHR for related work, consulting fees from taking part in advisory boards for AstraZeneca, GSK, Sanofi and Myralis, and honoraria payments for lectures from AstraZeneca, GSK and Sanofi; JD has participated on the Board of the New Zealand Environmental Protection Authority, which is independent and government-funded, and on the Board of the Health Research Council, both of which are unrelated to this work; PJC has been supported by an NIHR grant; all other authors declare no competing interests.
Funding Statement
The CAMERA project was supported by the European Research Council under ERC grants 668954, and 101020088. The SCAALA study was supported by the Wellcome Trust under grant 072405/Z/03/Z/WT. Work in Salvador was also supported by: Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) under grants PNE0003/2014 and PNX0001/2014; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) under finance code 001; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) under grant 308521/2019 and CNPq/ CONFAP/FAPESB under grant 40314. Work in Wellington was supported by the Health Research Council (HRC) of New Zealand and CB was supported by an HRC Sir Charles Hercus Fellowship. Work in Ecuador was supported by the Universidad Internacional del Ecuador under grant EDM-INV-04-19. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the London School of Hygiene & Tropical Medicine (LSHTM) ethics committee (ref: 26308)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos